N A Malkova

10PUBLICATIONS
56CO-AUTHORS
Epidemiological modellingAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Neurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 11, 2025
[Epidemiology of multiple sclerosis in the city of Novosibirsk].

I E Arkhipov, A I Prokaeva, E V Tretyakova

|Apr 27, 2024
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].

A N Boyko, V M Alifirova, I G Lukashevich

|Aug 10, 2023
[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].

A N Boyko, V M Alifirova, I G Lukashevich

|Aug 10, 2023
[POEMS-syndrome].

I E Arkhipov, I Yu Vergunova, N A Malkova

|Apr 21, 2023
[Efficacy and safety of divozilimab during 24-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-2].

A N Boyko, V M Alifirova, I G Lukashevich

|Feb 27, 2023
[Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results].

A N Boyko, K Z Bakhtiyarova, O V Boyko

Pageof 2

Frequent Collaborators

6 joint publications

L G Zaslavsky

6 joint publications

Ye V Parshina

6 joint publications

S A Sivertseva

6 joint publications

A V Zinkina-Orikhan